Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1384 |
|---|---|
| Identifier | NCT05119712 |
| Trial Title | Terbinafine Treatment of Axial Spondyloarthropathy |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ankylosing Spondylitis|Axial Spondyloarthritis|Psoriatic Spondylitis|Spondylitis Secondary to Inflammatory Bowel Disease|Axial Spondyloarthopathy |
| Interventions | DRUG: Terbinafine Tablets|DIAGNOSTIC_TEST: Laboratory Testing|DIAGNOSTIC_TEST: Laboratory Testing |
Participant Information
| Sponsor | Oregon Health and Science University |
|---|---|
| City | Portland |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | EARLY_PHASE1 |
Time Information
| Start Date | 2021-03-09 |
|---|---|
| Primary Completion Date | 2023-10-15 |
| Completion Date | 2024-10-15 |